Key result
Higher admission calcium linked to ~3.1-fold higher odds of favorable 90-day outcome after EVT.
Why the study?
The association between admission total serum calcium levels and clinical outcomes in patients with large ischemic stroke following endovascular treatment needed to be examined.
Does a higher admission total serum calcium level improve 90-day functional outcomes (mRS 0–3) and reduce mortality in patients with large ischemic stroke undergoing endovascular treatment?
Cohort (n=359)
Yes
Does a higher admission total serum calcium level improve 90-day functional outcomes (mRS 0–3) and reduce mortality in patients with large ischemic stroke undergoing endovascular treatment?
In patients with large ischemic stroke undergoing endovascular treatment, higher admission total serum calcium levels (>2.15 mmol/L) are independently associated with nearly triple the odds of favorable 90-day functional outcomes and significantly lower mortality, without affecting symptomatic intracranial hemorrhage rates.
Higher admission calcium may predict better EVT outcomes in large stroke; hypothesis-generating and should not change practice.
This study aimed to examine the association between admission total serum calcium (Ca) levels and clinical outcomes in patients with large ischemic stroke following endovascular treatment (EVT). This study is a subgroup analysis of a prospective cohort, including 359 patients who underwent EVT and had total serum calcium levels measured at admission. Patients were stratified into three groups based on their admission total serum calcium levels, categorized according to tertiles. The primary outcome was modified Rankin Scale (mRS) score 0–3 at 90 days. Safety outcomes included 90-day mortality and symptomatic intracranial hemorrhage (sICH) within 48 h. The 359 included patients were stratified according to tertiles of admission total serum calcium levels: Tertile 1 ( ≤ 2.15 mmol/L), Tertile 2 (2.16–2.28 mmol/L), and Tertile 3 ( > 2.28 mmol/L). Compared with patients in Tertile 1, those in Tertile 2 had significantly higher odds of achieving mRS 0–3 (adjusted odds ratio [aOR] 3.14, 95% CI 1.59–6.17, P = 0.001), and patients in Tertile 3 also demonstrated significantly increased odds of mRS 0–3 (aOR 2.57, 95% CI 1.31–5.03, P = 0.006). In addition, both higher tertiles were associated with significantly lower mortality compared with Tertile 1. There were no significant differences in the incidence of sICH among the three groups. In patients with large ischemic stroke undergoing EVT, an elevated admission serum calcium level was associated with a higher likelihood of mRS 0–3 and lower mortality. These findings suggest that blood calcium levels may serve as a potential prognostic biomarker for this population.
No takes yet. Share an insight, caveat, or question.
Jing et al. (2026) conducted a cohort in Large ischemic stroke due to anterior circulation large vessel occlusion undergoing endovascular treatment (n=359). Higher admission total serum calcium levels (Tertile 2: 2.16–2.28 mmol/L; Tertile 3: >2.28 mmol/L) vs. Lowest admission total serum calcium tertile (Tertile 1: ≤2.15 mmol/L) was evaluated on Favorable functional outcome (modified Rankin Scale score 0–3) at 90 days (Tertile 2 vs Tertile 1) (OR 3.14, 95% CI 1.59-6.17, p=0.001). Higher admission serum calcium levels (Tertile 2 and Tertile 3 vs Tertile 1) were significantly associated with increased odds of 90-day mRS 0–3 (aOR 3.14, P=0.001 and aOR 2.57, P=0.006) after EVT.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: